Kuliah Platelets Disorders
-
Upload
desi-adiyati -
Category
Documents
-
view
227 -
download
1
Transcript of Kuliah Platelets Disorders
-
8/9/2019 Kuliah Platelets Disorders
1/22
PLATELET
DISORDERS1. QUALITATIVE PLATELETDISORDERS 2. QUANTITATIVE PLATELET
DISORDERS a.THROMBOCYTOSIS
b.THROMBOCYTOPENIA
-
8/9/2019 Kuliah Platelets Disorders
2/22
QUALITATIVE PLATELET DISORDERSQualitative platelet disorders are suggested by a prolong! bl!"ng#"$ or %l"n"%al &"!n% o' bl!"ng "n #( )##"ng o' a nor$alpla#l# %o*n# an! %oag*la#"on )#*!").
Most commonly acquired, but can be inherited.
T)#) ar *)! #o !"agno) a pla#l# '*n%#"on !")or!rPa#"n#)*)p%#) a pla#l# '*n%#"on !")or!r +1. Complete family history.2.Laboratory tests :
Bl!"ng #"$!his measures the length of time it ta"es for a simplecut to stop
bleeding.Pla#l# aggrga#"on )#*!")!hese measure if there are
abnormalities in the #ay platelets clump together.
Von ,"llbran! -a%#or )#*!")!hese $nd out if the %on &illebrand'actor protein is #or"ing normally and rule out this similar disorder as the cause of thebleeding.
-
8/9/2019 Kuliah Platelets Disorders
3/22
ACQUIRED PLATELET DYS-UNCTION1.DRU/INDUCED!he most common drug isa. a)p"r"n ( the need to hold aspirin for ) days before elective surgery*.b.+ther drugs %lop"!ogrl0 #"%lop"!"n, and glycoprotein b-ainhibitors.
%.NSAID)inhibit cyclooygenase reversibly.E#(anol *) an! a)p"r"n #(rap (a& )nrg")#"% %#).!reatment : !")%on#"n*a#"on o' #( %*lpr"# !r*g, and in clinicallysigni$cant bleeding is pla#l# #ran)'*)"on .
2.UREMIA
t imparts a predisposition to bleeding that is "n%o$pl#l*n!r)#oo!.!he treatment involves correction of anemia, institution of hemodialysis,and the use of desmopressin -//0%latelet transfusions do not correct the coagulopathy because thetransfused platelets #ill assume the dysfunction of the uremic platelets.
-
8/9/2019 Kuliah Platelets Disorders
4/22
3.LIVER DISEASE&hether acute or chronic, is associated #ith platelet dysfunction that ismultifactorial in origin: "n%ra)! -DP) 'ro$ a%#"&a#"on o' #( 4br"nol#"%
pa#(5a %o$pro$") pla#l# '*n%#"on0 an! rla) o' pla#l# 'a%#or 3'ro$ pla#l#) is impaired in patients #ith cirrhosis or other cause of hepaticdysfunction.
.ACQUIRED VON ,ILLEBRAND DISEASE
).PARARANEOPLASTIC PLATELET DYS-UNCTION
t has also been associated #ith plasma cell dyscrasias and related to coating ofthe platelet membrane #ith paraproteins.Myelodysplasticand myeloproliferativesyndromes may result in plateletdysfunction .
!he bleeding time is often prolonged but does not correlate #ith the bleedingtendency.
Miscellaneous disorders associated #ith platelet dysfunction include:cardiopulmonary bypass or valvular defects, autoimmune disorders (systemiclupus erythematosus, rheumatoid arthritis, scleroderma*, and severe iron orfolate de$ciency.
INHERITED PLATELET DISORDERS!hey include the common von &illebrand disease and the less common
3lan4man5s thrombasthenia and 6ernard78oulier disease.VON ,ILLEBRAND DISEASE
http://www.clevelandclinicmeded.com/diseasemanagement/hematology/myelo/myelo.htmhttp://www.clevelandclinicmeded.com/diseasemanagement/hematology/mdisorders/mdisorders.htmhttp://www.clevelandclinicmeded.com/diseasemanagement/hematology/mdisorders/mdisorders.htmhttp://www.clevelandclinicmeded.com/diseasemanagement/hematology/myelo/myelo.htm -
8/9/2019 Kuliah Platelets Disorders
5/22
-
8/9/2019 Kuliah Platelets Disorders
6/22
DDAPDD0V promotes the release o 'W+ rom endothelial cells. It is efecti'e or patients ith t!pe 1 disease
has a 'ar!ing efect or patients ith t!pe 20 disease is relati'el! contraindicated in patients ith t!pe 2,disease. DD0V ma! also be helpul or patients ith t!pe 26 or 27 but is not helpul or patients ith t!pe$.4$DD0V can be gi'en intra'enousl! or subcutaneousl! at ).2 ;g ith aresponse noted as earl! as $) minutes later and lasting 9 to 12 hours.4$/he dose ma! be repeated in 12hours and then dail!. /he intranasal preparation is gi'en at a dose o 15) ;g or patients eighing less than5) 3g and $)) ;g or those eighing more than 5) 3g. 0 trial inusion is needed to assess the e&cac! otreatment and ade*uac! o proph!lactic use. 0d'erse efects include acial ?ushing headachesh!ponatremia ith continuous use and a potential or thrombotic e'ents.4$
+or serious bleeding or prior to ma@or surger! intermediate-purit! actor VIII concentrate is used to maintain
actor VIII le'els beteen 5)% and 1))% or $ to 1) da!s. 0 dose o 2) to $) IA at a dose o 5) mg and traneamic acid =25 mg ha'e been used or mild bleeding episodes and or dental procedures. /he! carr! a ris3 othrombotic e'ents.4:-51
/opical treatment or oral
-
8/9/2019 Kuliah Platelets Disorders
7/22
QUANTITATIVE PLATELET DISORDERSTHROMBOCYTOSIST(ro$bo%#o)")is the presence of high plateletcounts in the
blood( 9 ).-mm;*Counts over
-
8/9/2019 Kuliah Platelets Disorders
8/22
Ca*)) an! )$p#o$)T( %a*) o' ))n#"al #(ro$bo%#o)") ") *n6no5n.S%on!ar #(ro$bo%#o)") $a !&lop a) a r)*l# o'+a%*# ($orr(ag or "n'%#"onan$"aar#(r"#") an! o#(r %(ron"% "n7a$$a#"on)%an%r8r%")"ron !4%"n%$!"%a#"on%)#oporo)")r$o&al o' #( )pln 9)pln%#o$:
pol%#($"a &ra 9a !")or!r a%#"ng o#(r r! bloo! %ll)0 a) 5ll a)pla#l#):)#r)))*rgrS$p#o$)T5o o' &r #(r pa#"n#) 5(o (a& #(ro$bo%#o)") !o no# (a& an)$p#o$) o' #( !")a) a# #( #"$ o' !"agno)"). Yo*ngr pa#"n#) $a
r$a"n )$p#o$/'r 'or ar).Enlarg$n# o' #( )pln ") !#%#! "n ;
-
8/9/2019 Kuliah Platelets Disorders
9/22
O#(r )$p#o$) o' #(ro$bo%#o)") "n%l*!:bloody stoolsbruisingdi44iness
headachehemorrhageprolonged bleeding after having surgery or after having a tooth pulledredness or tingling of the hands and feet#ea"ness. n rare instances, the lymph nodes become enlargedT( ("g()# pla#l# %o*n#) *)*all pro!*% #( $o)# )&r)$p#o$). >ounger patients (especially #omen* may not havesymptoms, even though their platelet counts are very high.Co$pl"%a#"on)Complications of thrombocytosis include )#ro60 (ar# a##a%60 an!'or$a#"on o' bloo! %lo#) "n #( ar$) an! lg).8(o*l! b no#"4! 5(n&r bl!"ng ") *n8pla"n! orprolong! or #( pa#"n# !&lop)+chest or leg painconfusionnumbness#ea"ness
-
8/9/2019 Kuliah Platelets Disorders
10/22
D"agno)")!he patient5s symptoms suggest the presence of thrombocytosis.Bloo! #)#) %on4r$ #( !"agno)").
Bon $arro5 a)p"ra#"on (removal of a tissue sample for microscopic eamination* mayalso be performed.Tra#$n#
!he "ey to treating secondary thrombocytosis is #ra#"ng #( *n!rl"ng %on!"#"on.0ny patient #ho has thrombocytosis should be n%o*rag! no# #o )$o6.n young people #ho have no symptoms, this condition can remain stable for many years.
!hese patients should be monitored by a physician, but may not require treatment.Tra#$n# 'or pa#"n#) 5(o !o (a& )$p#o$) 'o%*)) on %on#roll"ng bl!"ng0pr&n#"ng #( 'or$a#"on o' bloo! %lo#)0 an! lo5r"ng pla#l# l&l).!reatment for secondary thrombocytosis involves treating the condition or diseaseresponsible for ecess platelet production.1.n 1??
-
8/9/2019 Kuliah Platelets Disorders
11/22
Progno)")Many patients #ith thrombocytosis remain free ofcomplications for long periods. Ao#ever, some
patients may die as a result of blood clots oruncontrolled bleeding.Pr&n#"on
!here is no "no#n #ay to prevent thrombocytosis.
-
8/9/2019 Kuliah Platelets Disorders
12/22
THROMBOCYTOPENIA
D4n"#"on!hrombocytopenia is de$ned as a platelet count less than
1),-mm;
!hrombocytopenia is the medical term for a lo# blood platelet count.
t can be caused by1.P!AT"!"T #$D"%P%&D#'T&$777mega3ar!oc!tes2.P!AT"!"T "*#"T%AT&$7778!persplenism;.$'%"A"D P!AT"!"T D"T%#'T&$ +++mega3ar!oc!tes
Co$$on S"gn) an! )$p#o$) o' a lo5 bloo! pla#l#%o*n# $a "n%l*!:P#%("a8uper$cial bleeding into the s"in that appears as a rash of pinpoint7si4ed reddish7purple spots (petechiae*, usually on the lo#er legs
Ea) or 8%))"& br*")"ng
Prolong! bl!"ng 'ro$ %*#)Spon#ano*) bl!"ng 'ro$ g*$) or no)Bloo! "n *r"n or )#ool)Un*)*all (a& $n)#r*al 7o5)Pro'*) bl!"ng !*r"ng )*rgrComplications may range from none to severe bleeding.
!hrombocytopenia usually improves by treating the underlying cause.f bleeding is severe777 need a blood or even a platelet transfusion.
-
8/9/2019 Kuliah Platelets Disorders
13/22
1.PLATELET UNDERPRODUCTION!he hallmar" of platelet underproduction is !%ra)! $arro5$ga6aro%#) (or, #hen available, a decreased peripheral
blood reticulated platelet count*.Co$$on %a*))1.infections (including A%*B2.drugs (frequently chemotherapy or ethanol, but othermedications in rare instances*B
;.radiotherapyB vitamin de$ciency (folate or vitamin 612*B.marro# in$ltration by tumor, storage disease, or marro#failure syndromes (such as myelodysplastic syndrome, acute orchronic leu"emias*.Manag$n#1.treatment of the underlying condition2.supportive platelet transfusions if needed.;.More recently, t#o recombinant thrombopoietin (!+* madetheir #ay into the clinical arena for the treatment ofchemotherapy7induced thrombocytopenia (recombinant humanthrombopoietin rAu!+ and pegylated recombinant
mega"aryocyte gro#th and development factor 37rAuM3/'>.
-
8/9/2019 Kuliah Platelets Disorders
14/22
2.PLATELET SEQUESTRATIONHpr)pln")$ from a variety of causes including liver disease ormalignancy may result in platelet sequestration . Mild to moderatethrombocytopenia is caused by platelet sequestration #hen there is anassociated mild reduction in neutrophil count and hemoglobin and #ith
minimal impairment of hematopoiesis on bone marro# eamination.f physical eamination fails to detect splenomegaly evaluation #ith*l#ra)onograp( or ra!"on*%l"! "$ag"ng ") r%o$$n!! #o!o%*$n# )plno$gal.
Manag$n#
treatment of the underlying condition and platelet transfusion as needed.Cytopenias secondary to hypersplenism are often not suDciently severeto #arrant treatment in the form of (total or partial* splenectomy,partial splenic emboli4ation or transEugular intrahepatic portosystemicshunting for congestive splenomegaly.
-
8/9/2019 Kuliah Platelets Disorders
15/22
Ca*)) o' Splno$galCirrhosis
Aeart failureortal or hepatic venous thrombosisMalignancies and hematologic disorders, including lymphoma, acute andchronic leu"emias, myeloproliferative disorders, metastatic solid tumors,and hemolytic anemiasnfectious disorders, including infection #ith pstein76arr virus,
cytomegalovirus, Falmonella ,rucella, tuberculosis, malaria,/ooplasma, and leishmanian$ltrative disease, including 3aucher5s disease, amyloidosis, andglycogen storage diseasesMiscellaneous disorders, including sarcoidosis, systemic lupuserythematosus, and 'elty5s syndrome
-
8/9/2019 Kuliah Platelets Disorders
16/22
3.INCREASED PLATELET DESTRUCTION!he hallmar" is increased marro# mega"aryocytes(or, #hen available, high reticulated platelet count*.latelet destruction results from a variety of immuneconditions including the follo#ing:mmune thrombocytopenic purpura!hrombotic microangiopathies
ost7transfusion purpura (!*Aeparin7induced thrombocytopenia (A!*/isseminated intravascular coagulation (/C*.
-
8/9/2019 Kuliah Platelets Disorders
17/22
IMMUNE THROMBOCYTOPENIC PURPURA 9ITP:!he incidence of ! 1
-
8/9/2019 Kuliah Platelets Disorders
18/22
PATHOPHYSIOLOY+!he pathophysiology o' pr"$ar ITP involves the formation of antiplatelet antibodies,frequently directed at platelet glycoproteins b-0, b-I, a-a, %, or multiple plateletantigens.
CLINICAL -EATURES++n history and physical eamination, the absence of systemic symptoms is helpful inruling out secondary causes. vidence of platelet7type (mucosal* bleeding should benoted, and the absence of splenomegaly supports the diagnosis. 6leeding is often lesspronounced than in cases of decreased production #ith similar platelet counts.1;71),1
-
8/9/2019 Kuliah Platelets Disorders
19/22
TREATMENT+
-"r)# pr)n#a#"on1.S#ro"!)+In the as!mptomatic patients ith a platelet count less than $))))
-
8/9/2019 Kuliah Platelets Disorders
20/22
Argent treatment or I/ patients ith neurologic de"cits or internal
bleeding or or emergenc! surger! includes meth!lprednisolone at adose o $) mg
-
8/9/2019 Kuliah Platelets Disorders
21/22
,(n #o )6 $!"%al a!&"%
Aave abnormal bleeding or bruising
/evelop a rash of pinpoint7si4ed red spots (petechiae*
6ecause some of the underlying causes ofthrombocytopenia are serious, it5s important to
promptly evaluate any signs or symptoms.f the patient ta"ing heparin and have severe orincreasing pain in leg777may be an indication of ablood clot deep in a vein in leg.
-
8/9/2019 Kuliah Platelets Disorders
22/22
L"')#l an! (o$ r$!")f platelet count is lo#7 avoiding drugs such as aspirin, #hich may impair platelet function, andavoidingecessive alcohol inta"e.
7 avoid contact sports, #hich can put you at a higher ris" of inEury andbleeding.
THE END